251 related articles for article (PubMed ID: 24315550)
21. Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study.
Kang TW; Lim HK; Lee MW; Kim YS; Rhim H; Lee WJ; Paik YH; Kim MJ; Ahn JH
Radiology; 2016 Jul; 280(1):300-12. PubMed ID: 26824711
[TBL] [Abstract][Full Text] [Related]
22. Treatment strategy to optimize radiofrequency ablation for liver malignancies.
Chen MH; Wei Y; Yan K; Gao W; Dai Y; Huo L; Yin SS; Zhang H; Poon RT
J Vasc Interv Radiol; 2006 Apr; 17(4):671-83. PubMed ID: 16614151
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous US-guided radiofrequency ablation of hepatocellular carcinomas: results in 15 patients.
Poggi G; Gatti C; Cupella F; Fiori M; Avanza F; Baldi M
Anticancer Res; 2001; 21(1B):739-42. PubMed ID: 11299836
[TBL] [Abstract][Full Text] [Related]
24. Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.
Lencioni R; Cioni D; Crocetti L; Franchini C; Pina CD; Lera J; Bartolozzi C
Radiology; 2005 Mar; 234(3):961-7. PubMed ID: 15665226
[TBL] [Abstract][Full Text] [Related]
25. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
Lu DS; Yu NC; Raman SS; Limanond P; Lassman C; Murray K; Tong MJ; Amado RG; Busuttil RW
Radiology; 2005 Mar; 234(3):954-60. PubMed ID: 15681691
[TBL] [Abstract][Full Text] [Related]
26. Local tumour progression after loco-regional therapy of hepatocellular carcinomas: value of fusion imaging-guided radiofrequency ablation.
Min JH; Lee MW; Rhim H; Cha DI; Lim S; Choi SY; Lim HK
Clin Radiol; 2014 Mar; 69(3):286-93. PubMed ID: 24332169
[TBL] [Abstract][Full Text] [Related]
27. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
[TBL] [Abstract][Full Text] [Related]
28. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
[TBL] [Abstract][Full Text] [Related]
29. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
[TBL] [Abstract][Full Text] [Related]
30. Radiofrequency ablation assisted by real-time virtual sonography for hepatocellular carcinoma inconspicuous under sonography and high-risk locations.
Lee CH; Chen WT; Lin CC; Teng W; Lin SM; Chiu CT
Kaohsiung J Med Sci; 2015 Aug; 31(8):413-9. PubMed ID: 26228280
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.
Llovet JM; Vilana R; Brú C; Bianchi L; Salmeron JM; Boix L; Ganau S; Sala M; Pagès M; Ayuso C; Solé M; Rodés J; Bruix J;
Hepatology; 2001 May; 33(5):1124-9. PubMed ID: 11343240
[TBL] [Abstract][Full Text] [Related]
32. Subphrenic versus nonsubphrenic hepatocellular carcinoma: combined therapy with chemoembolization and radiofrequency ablation.
Yamakado K; Nakatsuka A; Takaki H; Sakurai H; Isaji S; Yamamoto N; Shiraki K; Takeda K
AJR Am J Roentgenol; 2010 Feb; 194(2):530-5. PubMed ID: 20093620
[TBL] [Abstract][Full Text] [Related]
33. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
[TBL] [Abstract][Full Text] [Related]
34. Repeated percutaneous radiofrequency ablation for hepatocellular carcinoma in patients with cirrhosis: assessment of safety based on liver function and portal hypertension parameters.
Lee S; Jeong WK; Rhim H
J Vasc Interv Radiol; 2014 Oct; 25(10):1573-9. PubMed ID: 25108816
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.
Mikami S; Tateishi R; Akahane M; Asaoka Y; Kondo Y; Goto T; Shiina S; Yoshida H; Koike K
J Vasc Interv Radiol; 2012 Oct; 23(10):1269-75. PubMed ID: 22999746
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography.
Lee MW; Lim HK; Rhim H; Cha DI; Kang TW; Song KD; Min JH; Gwak GY; Kim S; Lu DSK
Can J Gastroenterol Hepatol; 2018; 2018():7926923. PubMed ID: 30013957
[TBL] [Abstract][Full Text] [Related]
37. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
Du J; Li HL; Zhai B; Chang S; Li FH
Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
[TBL] [Abstract][Full Text] [Related]
39. MR-guided radiofrequency ablation of hepatocellular carcinoma: long-term effectiveness.
Clasen S; Rempp H; Boss A; Schmidt D; Fritz J; Schraml C; Schick F; Claussen CD; Pereira PL
J Vasc Interv Radiol; 2011 Jun; 22(6):762-70. PubMed ID: 21530311
[TBL] [Abstract][Full Text] [Related]
40. Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
Woo S; Lee JM; Yoon JH; Joo I; Kim SH; Lee JY; Yoon JH; Kim YJ; Han JK; Choi BI
Radiology; 2013 Aug; 268(2):589-600. PubMed ID: 23513241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
